SARS-CoV-2 Variants in Patients with Immunosuppression

N Engl J Med. 2021 Aug 5;385(6):562-566. doi: 10.1056/NEJMsb2104756.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antiviral Agents / therapeutic use
  • COVID-19 / drug therapy
  • COVID-19 / virology*
  • Evolution, Molecular*
  • Humans
  • Immunocompromised Host*
  • Mutation
  • SARS-CoV-2 / drug effects
  • SARS-CoV-2 / genetics*

Substances

  • Antibodies, Monoclonal
  • Antiviral Agents

Supplementary concepts

  • SARS-CoV-2 variants